(Q77787988)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Solution-phase and solid-phase synthesis of novel transition state inhibitors of coagulation enzymes incorporating a piperidinyl moiety (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

A E Adang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A M Peters

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Gerritsma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

E de Zwart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G Veeneman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

number of pages

6

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1227-1232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

Challenges in the development of orally bioavailable thrombin active site inhibitors

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900179-1

7 January 2021

Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900179-1

7 January 2021

Novel acylguanidine containing thrombin inhibitors with reduced basicity at the P1 moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900179-1

7 January 2021

Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900179-1

7 January 2021

Lysine analogues as inhibitors of bacterial growth

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900179-1

7 January 2021

Peptide-derived transition state analogue inhibitors of thrombin; Synthesis, activity and selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900179-1

7 January 2021

10.1016/S0960-894X(99)00179-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10340604%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference